CARDIOMEDICALE
Board
3 directors, last change in 2023Director
since 18-08-2023
term until 18-08-2029
listed in the 2025 annual accounts, filed on 16-12-2025
Director (not named in the articles)
since 18-08-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 16-12-2025
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “2) pour une durée de six (6) ans, Madame , domiciliée à 5020 Namur (Champion), Rue de Fernelmont, 172, ici présente et qui accepte. Le…”deed of 08-09-2023
Mandates through the years
5 names, the dashed line is todayManager
Director
Board
Board
Manager
BoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
-
- Manager, since before 21-01-2016
-
- Director, from 23-11-2021 to date
-
- Board, from 23-11-2021 to date
-
- Board, from before 08-09-2023, no longer listed in the 2025 annual accounts
-
- Manager, from before 21-01-2016, no longer listed in the 2025 annual accounts
Control
Capital
- Contribution
- €12,400
- Shares
- 750
- Contribution per share
- €16.53
- Equity per share
- €1,177 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 08-09-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Tuesday of November at 20:00
Capital transactions
Capital over time
- 08-09-2023 Capital stated in the deed · 750 shares
- 20-12-2018 Capital reduction of €315,000 · to €18,600 · repaid to the shareholders